Kunming Biomed and BTS Research Announce Collaboration at ChinaBio® Partnering Forum

Kunming Biomed International (KBI) of southwest China formed a collaboration with BTS Research (BTS) of San Diego that gives BTS an exclusive license to import and distribute KBI’s non-human primates in the western United States. The agreement, signed during the ChinaBio® Partnering Forum held in Shanghai on April 15-16, 2015, also provides a platform for the two firms to co-market each other’s research services, enabling each company to provide a broad range of CRO services in China and the US. More details.... Share this with colleagues: // //